net assets of the Company have been worth more than the amount of the Company paid to purchase the Company’s subsidiaries. 4. Cost of sales amount Baht 571.10 million, an increase of Baht 60.96 million
Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for the year 2017 as follows:- Financial Position As at 31 December 2017, total consolidated assets
the transaction, Modern Company must adjust its business structure by buying out land and factory buildings as well as adjust all existing assets and liabilities of the company except tools, machinery
Memorandum on the entering into of transactions to those Listed Companies, the detail when calculating the above lists , it is 45.89 percent of the wholly assets of the Company at the date of 31th December
calculating the above lists , it is 45.57 percent of the wholly assets of the Company at the date of 31th December 2018 ( the maximum transaction value is calculated listed) In this regards, all the listed are
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
Ref.No.IVL004/11/2017 9th November 2017 President The Stock Exchange of Thailand Subject: Acquisition of PTA and Utility assets in Portugal Indorama Ventures Public Company Limited (“IVL”) would like to inform
transaction is equivalent to 0.031% of the Company’s net tangible assets, which is more than 0.03%, but less than 3% of the net tangible assets of the Company, it is considered a medium-size connected
net tangible assets, which is more than 0.03%, but less than 3% of the net tangible assets of the Company, it is considered a medium-size connected transaction and the type of normal business